CYCC Bio Green Med Solution Inc.


$ 1.86 $ -0.12 (-6.03 %)    

Friday, 24-Oct-2025 13:40:31 EDT
QQQ $ 618.13 $ 2.13 (0.34 %)
DIA $ 472.81 $ 2.94 (0.63 %)
SPY $ 678.12 $ 1.64 (0.24 %)
TLT $ 91.54 $ -0.02 (-0.02 %)
GLD $ 378.34 $ -0.19 (-0.05 %)
$ 1.94
$ 1.92
$ 1.85 x 100
$ 1.87 x 28
$ 1.87 - $ 2.02
$ 1.73 - $ 114.96
616,455
na
na
$ 1.33
na
TBD
na
na (na)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 cyclacel-pharmaceuticals-exchanges-series-c-warrants-for-559395-common-shares-in-agreement-with-accredited-investors

On September 4, 2025, Cyclacel Pharmaceuticals, Inc. (the "Company") entered into a Warrant Exchange Agreement (the ...

 cyclacel-pharmaceuticals-stock-up-346-in-massive-after-hours-rally

After sharing encouraging preclinical results for a potential biliary tract cancer treatment, Cyclacel Pharmaceuticals jumped 3...

 reported-earlier-cyclacel-announces-new-findings-supporting-use-of-plogosertib-in-biliary-tract-cancer-patients-with-high-bubr1-expression

  Biliary tract cancer (BTC) or cholangiocarcinoma is an aggressive tumor with poor prognosis 

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION